phospho foxo1 thr24 4g6 Search Results


phospho foxo1 thr24  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc phospho foxo1 thr24
Phospho Foxo1 Thr24, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho foxo1 thr24/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
phospho foxo1 thr24 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
monoclonal rabbit phospho-foxo1 (thr24) antibody 4g6  (Beyotime)
90
Beyotime monoclonal rabbit phospho-foxo1 (thr24) antibody 4g6
Monoclonal Rabbit Phospho Foxo1 (Thr24) Antibody 4g6, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal rabbit phospho-foxo1 (thr24) antibody 4g6/product/Beyotime
Average 90 stars, based on 1 article reviews
monoclonal rabbit phospho-foxo1 (thr24) antibody 4g6 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
forkhead transcription factor foxo 1  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc forkhead transcription factor foxo 1
Forkhead Transcription Factor Foxo 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/forkhead transcription factor foxo 1/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
forkhead transcription factor foxo 1 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
bcl-xl (b9429) antibody  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc bcl-xl (b9429) antibody
Bcl Xl (B9429) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bcl-xl (b9429) antibody/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
bcl-xl (b9429) antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
anti phospho foxo1  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc anti phospho foxo1
Anti Phospho Foxo1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti phospho foxo1/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
anti phospho foxo1 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
rapamycin mtor  (Cell Signaling Technology Inc)
99
Cell Signaling Technology Inc rapamycin mtor
The <t>Akt/mTOR/FOXO1</t> signaling pathway was associated with the antigliomas of XHP. (a) After being incubated with different doses of XHP, 2 µ M PTX or control medium for 24h, U-87 MG cells were lysed and subjected to western blot analysis of Akt, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 antibodies. (b) Western blot analysis of AKT, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 expression in U-87 MG cells after treatment with LY294002 (20 μ M), <t>Rapamycin</t> (50 nM), or NAC (5 mM) with or without XHP. (c) Confocal images of U-87 MG cells treated with XHP stained with anti-FOXO1 antibody. (d) Confocal images of U-87 MG cells treated with XHP were stained with anti-p-FOXO1 antibody. (e) Quantitative RT-PCR analysis of U-87 MG cells subjected to FOXO1-specific knockdown, results were normalized with GAPDH level and expressed as folds of control (n = 3, mean ± SD). (f) U-87 MG cells subjected to FOXO1-specific knockdown were assayed by western blot. (g) U-87 MG cells treated with XHP in the absence or presence of LY294002 (20 μ M), Rapamycin (50 nM), or FOXO1-specific siRNA (10 nM). The proportion of Annexin V positive cells was measured by flow cytometry. Data are mean ± SD of three different experiments. ∗P < 0.05, ∗∗P < 0.01 significantly different from the control.
Rapamycin Mtor, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapamycin mtor/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
rapamycin mtor - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
b cell lymphoma  (Cell Signaling Technology Inc)
97
Cell Signaling Technology Inc b cell lymphoma
The <t>Akt/mTOR/FOXO1</t> signaling pathway was associated with the antigliomas of XHP. (a) After being incubated with different doses of XHP, 2 µ M PTX or control medium for 24h, U-87 MG cells were lysed and subjected to western blot analysis of Akt, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 antibodies. (b) Western blot analysis of AKT, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 expression in U-87 MG cells after treatment with LY294002 (20 μ M), <t>Rapamycin</t> (50 nM), or NAC (5 mM) with or without XHP. (c) Confocal images of U-87 MG cells treated with XHP stained with anti-FOXO1 antibody. (d) Confocal images of U-87 MG cells treated with XHP were stained with anti-p-FOXO1 antibody. (e) Quantitative RT-PCR analysis of U-87 MG cells subjected to FOXO1-specific knockdown, results were normalized with GAPDH level and expressed as folds of control (n = 3, mean ± SD). (f) U-87 MG cells subjected to FOXO1-specific knockdown were assayed by western blot. (g) U-87 MG cells treated with XHP in the absence or presence of LY294002 (20 μ M), Rapamycin (50 nM), or FOXO1-specific siRNA (10 nM). The proportion of Annexin V positive cells was measured by flow cytometry. Data are mean ± SD of three different experiments. ∗P < 0.05, ∗∗P < 0.01 significantly different from the control.
B Cell Lymphoma, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b cell lymphoma/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
b cell lymphoma - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier
phospho mtor ser2448  (Cell Signaling Technology Inc)
99
Cell Signaling Technology Inc phospho mtor ser2448
The <t>Akt/mTOR/FOXO1</t> signaling pathway was associated with the antigliomas of XHP. (a) After being incubated with different doses of XHP, 2 µ M PTX or control medium for 24h, U-87 MG cells were lysed and subjected to western blot analysis of Akt, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 antibodies. (b) Western blot analysis of AKT, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 expression in U-87 MG cells after treatment with LY294002 (20 μ M), <t>Rapamycin</t> (50 nM), or NAC (5 mM) with or without XHP. (c) Confocal images of U-87 MG cells treated with XHP stained with anti-FOXO1 antibody. (d) Confocal images of U-87 MG cells treated with XHP were stained with anti-p-FOXO1 antibody. (e) Quantitative RT-PCR analysis of U-87 MG cells subjected to FOXO1-specific knockdown, results were normalized with GAPDH level and expressed as folds of control (n = 3, mean ± SD). (f) U-87 MG cells subjected to FOXO1-specific knockdown were assayed by western blot. (g) U-87 MG cells treated with XHP in the absence or presence of LY294002 (20 μ M), Rapamycin (50 nM), or FOXO1-specific siRNA (10 nM). The proportion of Annexin V positive cells was measured by flow cytometry. Data are mean ± SD of three different experiments. ∗P < 0.05, ∗∗P < 0.01 significantly different from the control.
Phospho Mtor Ser2448, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho mtor ser2448/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
phospho mtor ser2448 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
phospho akt ser473  (Cell Signaling Technology Inc)
99
Cell Signaling Technology Inc phospho akt ser473
The <t>Akt/mTOR/FOXO1</t> signaling pathway was associated with the antigliomas of XHP. (a) After being incubated with different doses of XHP, 2 µ M PTX or control medium for 24h, U-87 MG cells were lysed and subjected to western blot analysis of Akt, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 antibodies. (b) Western blot analysis of AKT, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 expression in U-87 MG cells after treatment with LY294002 (20 μ M), <t>Rapamycin</t> (50 nM), or NAC (5 mM) with or without XHP. (c) Confocal images of U-87 MG cells treated with XHP stained with anti-FOXO1 antibody. (d) Confocal images of U-87 MG cells treated with XHP were stained with anti-p-FOXO1 antibody. (e) Quantitative RT-PCR analysis of U-87 MG cells subjected to FOXO1-specific knockdown, results were normalized with GAPDH level and expressed as folds of control (n = 3, mean ± SD). (f) U-87 MG cells subjected to FOXO1-specific knockdown were assayed by western blot. (g) U-87 MG cells treated with XHP in the absence or presence of LY294002 (20 μ M), Rapamycin (50 nM), or FOXO1-specific siRNA (10 nM). The proportion of Annexin V positive cells was measured by flow cytometry. Data are mean ± SD of three different experiments. ∗P < 0.05, ∗∗P < 0.01 significantly different from the control.
Phospho Akt Ser473, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho akt ser473/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
phospho akt ser473 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
akt pan  (Cell Signaling Technology Inc)
99
Cell Signaling Technology Inc akt pan
The <t>Akt/mTOR/FOXO1</t> signaling pathway was associated with the antigliomas of XHP. (a) After being incubated with different doses of XHP, 2 µ M PTX or control medium for 24h, U-87 MG cells were lysed and subjected to western blot analysis of Akt, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 antibodies. (b) Western blot analysis of AKT, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 expression in U-87 MG cells after treatment with LY294002 (20 μ M), <t>Rapamycin</t> (50 nM), or NAC (5 mM) with or without XHP. (c) Confocal images of U-87 MG cells treated with XHP stained with anti-FOXO1 antibody. (d) Confocal images of U-87 MG cells treated with XHP were stained with anti-p-FOXO1 antibody. (e) Quantitative RT-PCR analysis of U-87 MG cells subjected to FOXO1-specific knockdown, results were normalized with GAPDH level and expressed as folds of control (n = 3, mean ± SD). (f) U-87 MG cells subjected to FOXO1-specific knockdown were assayed by western blot. (g) U-87 MG cells treated with XHP in the absence or presence of LY294002 (20 μ M), Rapamycin (50 nM), or FOXO1-specific siRNA (10 nM). The proportion of Annexin V positive cells was measured by flow cytometry. Data are mean ± SD of three different experiments. ∗P < 0.05, ∗∗P < 0.01 significantly different from the control.
Akt Pan, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/akt pan/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
akt pan - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
caspase 9  (Cell Signaling Technology Inc)
97
Cell Signaling Technology Inc caspase 9
The <t>Akt/mTOR/FOXO1</t> signaling pathway was associated with the antigliomas of XHP. (a) After being incubated with different doses of XHP, 2 µ M PTX or control medium for 24h, U-87 MG cells were lysed and subjected to western blot analysis of Akt, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 antibodies. (b) Western blot analysis of AKT, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 expression in U-87 MG cells after treatment with LY294002 (20 μ M), <t>Rapamycin</t> (50 nM), or NAC (5 mM) with or without XHP. (c) Confocal images of U-87 MG cells treated with XHP stained with anti-FOXO1 antibody. (d) Confocal images of U-87 MG cells treated with XHP were stained with anti-p-FOXO1 antibody. (e) Quantitative RT-PCR analysis of U-87 MG cells subjected to FOXO1-specific knockdown, results were normalized with GAPDH level and expressed as folds of control (n = 3, mean ± SD). (f) U-87 MG cells subjected to FOXO1-specific knockdown were assayed by western blot. (g) U-87 MG cells treated with XHP in the absence or presence of LY294002 (20 μ M), Rapamycin (50 nM), or FOXO1-specific siRNA (10 nM). The proportion of Annexin V positive cells was measured by flow cytometry. Data are mean ± SD of three different experiments. ∗P < 0.05, ∗∗P < 0.01 significantly different from the control.
Caspase 9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caspase 9/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
caspase 9 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier
caspase 3  (Cell Signaling Technology Inc)
99
Cell Signaling Technology Inc caspase 3
The <t>Akt/mTOR/FOXO1</t> signaling pathway was associated with the antigliomas of XHP. (a) After being incubated with different doses of XHP, 2 µ M PTX or control medium for 24h, U-87 MG cells were lysed and subjected to western blot analysis of Akt, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 antibodies. (b) Western blot analysis of AKT, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 expression in U-87 MG cells after treatment with LY294002 (20 μ M), <t>Rapamycin</t> (50 nM), or NAC (5 mM) with or without XHP. (c) Confocal images of U-87 MG cells treated with XHP stained with anti-FOXO1 antibody. (d) Confocal images of U-87 MG cells treated with XHP were stained with anti-p-FOXO1 antibody. (e) Quantitative RT-PCR analysis of U-87 MG cells subjected to FOXO1-specific knockdown, results were normalized with GAPDH level and expressed as folds of control (n = 3, mean ± SD). (f) U-87 MG cells subjected to FOXO1-specific knockdown were assayed by western blot. (g) U-87 MG cells treated with XHP in the absence or presence of LY294002 (20 μ M), Rapamycin (50 nM), or FOXO1-specific siRNA (10 nM). The proportion of Annexin V positive cells was measured by flow cytometry. Data are mean ± SD of three different experiments. ∗P < 0.05, ∗∗P < 0.01 significantly different from the control.
Caspase 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caspase 3/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
caspase 3 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


The Akt/mTOR/FOXO1 signaling pathway was associated with the antigliomas of XHP. (a) After being incubated with different doses of XHP, 2 µ M PTX or control medium for 24h, U-87 MG cells were lysed and subjected to western blot analysis of Akt, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 antibodies. (b) Western blot analysis of AKT, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 expression in U-87 MG cells after treatment with LY294002 (20 μ M), Rapamycin (50 nM), or NAC (5 mM) with or without XHP. (c) Confocal images of U-87 MG cells treated with XHP stained with anti-FOXO1 antibody. (d) Confocal images of U-87 MG cells treated with XHP were stained with anti-p-FOXO1 antibody. (e) Quantitative RT-PCR analysis of U-87 MG cells subjected to FOXO1-specific knockdown, results were normalized with GAPDH level and expressed as folds of control (n = 3, mean ± SD). (f) U-87 MG cells subjected to FOXO1-specific knockdown were assayed by western blot. (g) U-87 MG cells treated with XHP in the absence or presence of LY294002 (20 μ M), Rapamycin (50 nM), or FOXO1-specific siRNA (10 nM). The proportion of Annexin V positive cells was measured by flow cytometry. Data are mean ± SD of three different experiments. ∗P < 0.05, ∗∗P < 0.01 significantly different from the control.

Journal: Evidence-based Complementary and Alternative Medicine : eCAM

Article Title: Xihuang Pill Induces Apoptosis of Human Glioblastoma U-87 MG Cells via Targeting ROS-Mediated Akt/mTOR/FOXO1 Pathway

doi: 10.1155/2018/6049498

Figure Lengend Snippet: The Akt/mTOR/FOXO1 signaling pathway was associated with the antigliomas of XHP. (a) After being incubated with different doses of XHP, 2 µ M PTX or control medium for 24h, U-87 MG cells were lysed and subjected to western blot analysis of Akt, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 antibodies. (b) Western blot analysis of AKT, p-Akt, mTOR, p-mTOR, FOXO1, and p-FOXO1 expression in U-87 MG cells after treatment with LY294002 (20 μ M), Rapamycin (50 nM), or NAC (5 mM) with or without XHP. (c) Confocal images of U-87 MG cells treated with XHP stained with anti-FOXO1 antibody. (d) Confocal images of U-87 MG cells treated with XHP were stained with anti-p-FOXO1 antibody. (e) Quantitative RT-PCR analysis of U-87 MG cells subjected to FOXO1-specific knockdown, results were normalized with GAPDH level and expressed as folds of control (n = 3, mean ± SD). (f) U-87 MG cells subjected to FOXO1-specific knockdown were assayed by western blot. (g) U-87 MG cells treated with XHP in the absence or presence of LY294002 (20 μ M), Rapamycin (50 nM), or FOXO1-specific siRNA (10 nM). The proportion of Annexin V positive cells was measured by flow cytometry. Data are mean ± SD of three different experiments. ∗P < 0.05, ∗∗P < 0.01 significantly different from the control.

Article Snippet: Mammalian target of rapamycin (mTOR) (2983), phospho-mTOR (Ser2448) (5536), Akt (pan) (4691), phospho-Akt (Ser473) (4060), forkhead transcription factor (FOXO)-1 (C29H4) (2880), phospho-FOXO1 (Thr24) (4G6) (2599), caspase-3 (9662), caspase-9 (9508), B-cell lymphoma-extra large (Bcl-xL) (B9429), Bcl-2-associated X protein (Bax) (5023), and GAPDH (5174) primary antibodies were purchased from Cell Signaling Technology.

Techniques: Incubation, Control, Western Blot, Expressing, Staining, Quantitative RT-PCR, Knockdown, Flow Cytometry